Healthcare News

REYKJAVIK, Iceland, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture...

REYKJAVIK, ICELAND (August 19, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar...

Alvotech birtir í dag uppgjör fyrir fyrstu sex mánuði ársins 2026 og fjallar um nýlega áfanga í rekstri félagsins. Ítarlegri útgáfu á ensku er að finna á vefsíðu félagsins fyrir fjárhagsupplýsingar:...

PARSONS, Kan., Aug. 19, 2026 (GLOBE NEWSWIRE) -- {{DATELINECITY_DATE_GLOBENEWSWIRE_BUG}ReNu Medical & Spa is proud to announce the opening of its newest location in Parsons, Kansas, expanding...

TARRYTOWN, N.Y., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: 2026 Wells Fargo Healthcare Conference at 8:45...

HIGH POINT, N.C., Aug. 19, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential...

Longeveron has appointed Nirav Jhaveri, CFA, as Chief Financial Officer. He has over 25 years of experience in capital markets and corporate finance.

Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics...

WOBURN, Mass., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a commercial stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today...